Cellular signalling by lipoprotein receptors

Current Opinion in Lipidology

Volumn 11, Issue 2, 2000, Pages 161-166

  Herz, Joachim ^a   Gotthardt, Michael ^a   Willnow, Thomas E ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; AMYLOID BETA PROTEIN; HORMONE; LIPOPROTEIN; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; MEGALIN; TAU PROTEIN; VITAMIN;

ALZHEIMER DISEASE; CELL SURFACE; ENDOCYTOSIS; HOMEOSTASIS; HUMAN; LIPOPHILICITY; MEMBRANE TRANSPORT; METABOLISM; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; CELL COMMUNICATION; CELL MEMBRANE; HEYMANN NEPHRITIS ANTIGENIC COMPLEX; HORMONES; HUMANS; MEMBRANE GLYCOPROTEINS; MODELS, BIOLOGICAL; RECEPTORS, LIPOPROTEIN; SIGNAL TRANSDUCTION; VITAMINS;

EID: 0034006370     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200004000-00009     Document Type: Review

References (36)

1. 1 Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 1994; 63:601-637.
2. 2 Kozyraki R, Fyfe J, Kristiansen M, Gerdes C, Jacobsen C, Cui S, et al. The intrinsic factor-vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein. Nature Med 1999; 5:656-661. Experimental evidence is presented that the intrinsic factor receptor cubilin binds apolipoprotein A-I and mediates the endocytosis of HDL particles.
3. •] that implicates the cell surface-associated protein cubilin in endocytosis of HDL particles.
4. 4 Rohlmann A, Gotthardt M, Hammer RE, Herz J. Inducible inactivation of hepatic LRP gene by Cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J Clin Invest 1998; 101:689-695. LDL receptor-deficient mice in which LRP has also been inactivated in the liver by tissue-specific gene targeting show impaired clearance of chylomicron remnants from the circulation and are hyperlipidaemic.
5. 5 Wetterau JR, Aggerbeck LP, Bouma ME, Eisenberg C, Munck A, Hermier M, et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 1992; 258:999-1001.
6. 6 Sharp D, Blinderman L, Combs KA, Kienzle B, Ricci B, Wager-Smith K, et al. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature 1993; 365:65-69.
7. 7 Ouahchi K, Arita M, Kayden H, Hentati F, Ben Hamida M, Sokol R, et al. Ataxia with isolated vitamin E deficiency is caused by mutations in the alphatocopherol transfer protein. Nature Genet 1995; 9:141-145.
8. 8 Vieira AV, Kuchler K, Schneider WJ. Retinol in avian oogenesis: molecular properties of the carrier protein. DNA Cell Biol 1995; 14:403-410.
9. 9 Safadi FF, Thornton P, Magiera H, Hollis BW, Gentile M, Haddad JG, et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 1999; 103:239-251. Detailed characterization of the vitamin D and bone metabolism in DBP knockout mice is given. Absence of DBP results in bone formation defects due to plasma vitamin D deficiency. DBP is proposed to maintain serum vitamin D pools and to regulate tissue-specific delivery of vitamin D metabolites.
10. 10 Christensen EI, Moskaug JO, Vorum H, Jacobsen C, Gundersen TE, Nykjaer A, et al. Evidence for an essential role of megalin in transepithelial transport of retinol. J Am Soc Nephrol 1999; 10:685-695. Urinary excretion of RBP and retinol in megalin-deficient mice suggests an essential role for the receptor in tubular retrieval of vitamin A-carrier complexes.
11. 3 from the glomerular filtrate and develop vitamin D deficiency and bone formation defects.
12. 12 Quadro L, Blaner WS, Salchow DJ, Vogel S, Piantedosi R, Gouras P, et al. Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. EMBO J 1999; 18:4633-4644. RBP-knockout mice are unable to mobilize hepatic retinol upon vitamin A starvation. They exhibit reduced plasma retinol levels and suffer from impaired retinal function.
13. 13 Farese RV, Herz J. Cholesterol metabolism and embryogenesis. Trends in Genetics 1998; 14:115-120. A discussion of the function of the rodent yolk sac in embryonic lipid metabolism and brain development is provided.
14. 14 Raabe M, Flynn LM, Zlot CH, Wong JS, Veniant MM, Hamilton RL, Young SG. Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc Natl Acad Sci USA 1998; 95:8686-8691. MTP-deficient mouse embryos die in utero. The visceral endoderm of their yolk sacs displays massive accumulation of lipids and virtual absence of de-novo lipoprotein biosynthesis. The inability of the yolk sac to export maternal lipids to the embryo is held responsible for the embryonic lethality.
15. 15 Tosetti F, Campelli F, Levi G. Studies on the cellular uptake of retinol binding protein and retinol. Exp Cell Res 1999; 250:423-433. HepG2 hepatocarcinoma cells and Caki-1 kidney adenocarcinoma cells take up retinol via receptor-mediated endocytosis of RBP-retinol complexes and resecrete retinol bound to newly synthesized RBP.
16. 16 Sundaram M, Sivaprasadarao A, DeSousa MM, Findlay JB. The transfer of retinol from serum retinol-binding protein to cellular retinol-binding protein is mediated by a membrane receptor. J Biol Chem 1998; 273:3336-3342. Transfer of retinol from RBP onto cellular retinol-binding proteins requires the presence of permeabilized placental membranes, suggesting the existence of a membrane-associated RBP receptor.
17. 17 Maitra US, Khan MS, Rosner W. Corticosteroid-binding globulin receptor of the rat hepatic membrane: solubilization, partial characterization, and the effect of steroids on binding. Endocrinology 1993; 133:1817-1822.
18. 18 Fortunati N. Sex hormone-binding globulin: not only a transport protein. What news is around the corner? J Endocrinol Invest 1999; 22:223-234.
19. 19 Rosner W, Hryb DJ, Khan MS, Nakhla AM, Romas NA. Androgen and estrogen signaling at the cell membrane via G-proteins and cyclic adenosine monophosphate. Steroids 1999; 64:100-106.
20. 20 Goretzki L, Mueller BM. Low-density-lipoprotein-receptor-related protein (LRP) interacts with a GTP-binding protein. Biochem J 1998; 336:381-386. The LRP is found in a complex with a G-protein and stimulates cyclic adenosine monophosphate formation.
21. 21 Riddell DR, Graham A, Owen JS. Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease. J Biol Chem 1997; 272:89-95.
22. 22 Riddell DR, Vinogradov DV, Stannard AK, Chadwick N, Owen JS. Identification and characterization of LRP8 (apoER2) in human blood platelets. J Lipid Res 1999; 40:1925-1930. ApoER2 is found in platelets. Is ApoER2 mediating the apolipoprotein E induced stimulation of nitric oxide synthase and inhibition of platelet aggregation?
23. 23 Hsu HY, Hajjar DP, Khan KM, Falcone DJ. Ligand binding to macrophage scavenger receptor-A induces urokinase-type plasminogen activator expression by a protein kinase-dependent signaling pathway. J Biol Chem 1998; 273:1240-1246. Ligands for scavenger receptor type A stimulate cellular tyrosine kinases. A role for scavenger receptor type A in direct transmembrane signalling?
24. 24 Trommsdorff M, Borg JP, Margolis B, Herz J. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J Biol Chem 1998; 273:33556-33560. 'NPxY' sequence motifs in the LDL receptor and LRP were found to bind the cytoplasmic adaptor and scaffold proteins Disabled-1 and FE65. A larger complex on the LRP tail may link APP, LRP, Disabled-1, and mammalian enabled (Mena), and thus alter the stability of the cytoskeleton locally.
25. 25 Gertler FB, Bennett RL, Clark MJ, Hoffmann FM. Drosophila abl tyrosine kinase in embryonic CNS axons: a role in axonogenesis is revealed through dosage-sensitive interactions with disabled. Cell 1989; 58:103-113.
26. 26 Howell BW, Lanier LM, Frank R, Gertler FB, Cooper JA. The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids. Mol Cell Biol 1999; 19:5179-5188. In a reverse screen, Disabled-1 was found to bind to the LRP and APP tails, but also to other cytoplasmic proteins containing 'NPxY' motifs. A phospholipid binding domain presumably recruits Disabled-1 to the plasma membrane.
27. 27 Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, Nimpf J, et al. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 1999; 97:689-701. Gene knockout experiments in mice reveal an essential role for ApoER2 and VLDL receptor in the regulation of neuronal positioning and suggest a linear signaling pathway involving Reelin, VLDL receptor, ApoER2 and Disabled-1.
28. 28 Howell BW, Hawkes R, Soriano P, Cooper JA. Neuronal position in the developing brain is regulated by mouse disabled-1. Nature 1997; 389:733-737.
29. 29 Rice DS, Curran T. Mutant mice with scrambled brains: understanding the signaling pathways that control cell positioning in the CNS. Genes Dev 1999; 13:2758-2773. This superb review summarizes the molecular processes that govern neuronal migration and positioning.
30. 30 Howell BW, Gertler FB, Cooper JA. Mouse disabled (mDab1): a Src binding protein implicated in neuronal development. EMBO J 1997; 16:121-132.
31. 31 Howell BW, Herrick TM, Cooper JA. Reelin-induced tyrosine phosphorylation of disabled 1 during neuronal positioning. Genes Dev 1999; 13:643-648. This study showed that Reelin induces tyrosine phosphorylation of Disabled-1 in neurones during development, but not in postmitotic neurones that have completed migration. It further shows that Disabled-1 and Reelin mutations are nonadditive, indicating that both genes function in a linear pathway.
32. 32 Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, Cooper JA, Herz J. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 1999; 24:481-489. This paper demonstrates the direct biochemical interaction of Reelin with the extracellular domains of ApoER2 and VLDL receptor, and shows that this interaction is required for tyrosine phosphorylation of Disabled-1. Mice with mutations in the Reeler pathway show also increases in tau phosphorylation, suggesting that neuronal apolipoprotein E receptors can modulate a key process that leads to neurofibrillary tangles in Alzheimer's disease.
33. ••] that shows that apolipoprotein E can interfere with Reelin binding to ApoER2 and VLDL receptor.
34. 34 Gould E, Reeves AJ, Graziano MS, Gross CG. Neurogenesis in the neocortex of adult primates. Science 1999; 286:548-552. Neurogenesis and neuronal migration is found to occur in the brains of adult animals. Is this process key to neuronal regeneration and can it explain neuronal loss in Alzheimer's disease? Are neuronal apolipoprotein E receptors involved?
35. 35 Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90:9649-9653.
36. 36 Hass S, Fresser F, Kochl S, Beyreuther K, Utermann G, Baier G. Physical interaction of ApoE with amyloid precursor protein independent of the amyloid Abeta region in vitro. J Biol Chem 1998; 273:13892-13897. Apolipoprotein E was shown to bind to the APP independent of its known interaction with the β-peptide. This is another mechanism by which apolipoprotein E could affect intracellular APP routing and processing.